Establishing a new bio-mathematical model, named quantitative LQ-based (qLQB) model, that can evaluate the radio-toxicity of lung. We assume that each Function Subunit (FSU) of lung is equal and representative in functional status. Based on the Linear-Quadratic model (LQ model), we had derived a model to calculate the ratio/percent (R/P) between damaged cell/FSU and entire cell/FSU of lung for radiation dose response. We can analyse radiation pneumonia probability (RPP) based on the R/P. Forty-five 3D plans from forty-five randomly selected lung cancer patients were generated using the ELEKTA precise 2.12 treatment planning system. The qLQB was tested against the widely used Lyman-Kutcher-Burman model (LKB model). There was no distinct statistical difference in analyzing RPP between using the qLQB model and the LKB model (p 5 0.412). The proposed qLQB model was found to be efficient and reliable for analyzing RPP.
Introduction
Today, cancer patients have longer survival rates due to improved therapy methods. Some advanced treatment planning tools that use biologically related models for plan optimization and/or evaluation are being introduced for clinical use. A variety of dose response models and quantities along with a series of organ-specific model parameters are included in these tools (1) (2) (3) (4) . However, due to various limitations, such as the limitations of models and available model parameters, the incomplete understanding of dose responses, and the inadequate clinical data, the use of a biologically based treatment planning system represents a paradigm shift and can be potentially dangerous (5) (6) (7) (8) .
An important goal of evaluating treatment plan before delivery is to know tumor control probability (TCP) and normal tissue complication probability (NTCP). In a treatment plan, tumor dose is often at narrow dose-interval and dose exposed on normal tissue is distributed: from zero to prescribed dose. This make understanding dose-response rationale of normal tissue is more difficult than of tumor, especially when the normal tissue with parallel feature (Parallel Organ) (9) (10) (11) . Volume 14 Number 5 October 2015 Technology in Cancer Research & Treatment 2014 June 30. Epub ahead of print Because the upper limit dose of normal tissue with serial feature (Serial Organ) is determined by the maximum dose, but the upper limit dose of Parallel Organ is simply not determined by the certain dose. Until recently, radiotherapist evaluate dose-response of Parallel Organ by assembling several doses and their related-volume (12) (13) (14) , such as V 5 (the volume covered by 5 Gy), V 20 , V 50 and mean dose, etc. This evaluating method is clinically called dose-volume (DV) parameters method/model. Lung is classical Parallel Organ, therefore DV parameters method is often used to evaluate lung complication probability in radiotherapy. Usually, radiotherapist utilize dose-volume parameters, such as V 5 , V 20 , V 50 and mean lung dose (MLD), to evaluate lung injury in radiotherapy (13) (14) (15) . But the method has a fatal defect, we will next demonstrate the defect. To overcome the fatal defect of DV parameters method, the author and his collaborators have established a new model based on linear quadratic (LQ) model for evaluating lung injure in radiotherapy, and test its effectiveness against Lyman-Kutcher-Burman (LKB) model.
Materials and Methods
Radiotherapists often utilize dose-volume parameters such as V 5 , V 20 , V 50 and MLD to determine the quality of the treatment plans. However, these parameters often have discrepancies between two plans designed for the same patient. We often find the situation as follows: with the target dose reaching the clinical requirement, the V 20 within lung is 18% in the plan 2, which is lower than the plan 1 (V 20 within lung is 22%). However, V 5 and V 10 within the lung volume are 47% and 39% respectively in the plan 2, which are much higher than those in the plan 1 (V 5 and V 10 within the lung volume in the plan 1 are 27% and 25%). In this case, we are confused over which is the best plan to choose for the patient. Because for radiation pneumonitis, the importance between "high doses to small volumes" and "low doses to large volumes" is disputed (16, 17) (Figure 1 ).
Lung consists of parallel Function Subunits (FSUs) with each FSU being equal and representative in functional status. Some FSUs of lung are damaged and can not affect the others. It can be seen that the level of lung injury is related with the number of damaged FSUs. When there are more damaged FSUs, the radio-toxicity of the lung is more severe. Previous studies have shown that FSU unfunction is attributed to some kinds of cells damaged in the FSU. When evaluating plan or comparing two plans of the same patient, if we can convert the lung's exposed dose to the number of damaged cells (or the number of survival cells), we can assess the quality of the plan or select the better of two plans easily by comparing the number of damaged cells (or the number of survival cells). In other words, when the survival number of the cells is greater, the NTCP is lower, regardless of the V 5 , V 20 , V 50 and MLD comparisons.
Under this thought, the author and his cooperator have established the qLQB model, based on LQ model and dosevolume-differential-histogram (dDVH) in radiation plans, to calculate the ratio/percent (R/P) between damaged cell/ FSU and entire cell/FSU of lung for radiation dose response. Then test the qLQB against the widely used LKB model. The qLQB model can be described by a formulae:
Here, A is the number of cells in a unit; V s is the integral volume of lung; D max is the maximum dose which is exposed on lung per fraction in the plan. f 1 (D) is the percentage volume of lung which is exposed at dose D. V is the integral exposed volume of lung. α and β are dimensionless parameter, which are determined by the organ character.
The process of the qLQB establishment and brief descriptions of the LKB model are given in Appendix I. We used the dDVH, shown in Figure 2 . The parameters used for normal lung tissue are α 5 0.031 Gy 21 (0.003,0.059), β 5 0.010 Gy 21 (0.007,0.013), α/β 5 3.07 Gy (-0.23,8.46) in this paper (18) . Then we converted equation [1] into a computer program. In the program, A is endowed with any constant, because A is 
Results
Import 45 patients' dDVHs into the computer program, Figure 3 shows the computer program interface of importing some patient's dDVH. With n being the number of irradiation fractions, we get 650 discrete points (the number of points is determined by dDVH's pixel). A have no effect on RP value, so by taking A 5 1.
The results were contrasted with the results from Lyman-Kutcher-Burman (LKB) model by SPSS17.0 software, p 5 0.412. There is no distinct statistical difference in evaluating plan quality between using LQB model and LKB model.
Discussion and Conclusion
Radiation-induced pulmonary injury (RIPI) is usual problem when treating lung cancer, mediastinal tumor and breast cancer. Clinical practice indicates that the level of RIPI is related with exposed-volume of lung and dose exposed on the volume. A Radiation Therapy Oncology Group (RTOG) (5) study found that V 20 is apparently related to the incidence rate of radiation pneumonitis and its subsequent severity. Subsequent clinical investigators found that when considering a plan for the lung, we not only evaluate V 20 in lung but also V 5 , V 10 (low dose for big volume) in lung, and V 30 , V 50 (high dose for small volume) in lung.
To reflect the complex radiation effects of lung, we need to know more than just V x which is defined by the volume exposed with the dose D and the 'exceeded' D, because the "exceed" in the definition of "V x " hides a lot of information that is probably very important. The qLQB model model is raised based on overcoming the defect of Vx model and uses the dDVH which is based on all V x , and use damaged RP to evaluate level of RIPI.
We test the effectiveness of the qLQB model against the LKB model, acquiring p  0.05, indicating that use of the LKB model or the LQ-based model will obtain the same results for evaluating level of RIPI.
Lyman established sigmoidal-dose-response integral model, which can be used to describe dose response only when integral organ or partial organ absorbs some uniform dose. With the development of irradiation oncology, non-uniform degree of normal organs absorb dose increases. Although Kutcher and Burman had improved the integral model, non-uniform dose must be convert some uniform dose before using the integral model. But qLQB model is based on LQ model, which can be used to describe dose response directly using non-uniform dose. LKB model is an experiential model based on four parameters, and the base of qLQB model, LQ model, was from a radiation biology experiment, which is more reliable than experiential parameters. Finally, qLQB is not only based on in vitro LQ model but also based on in vivo LQ model, which can increase consistency between calculation base on qLQB model, if which is based on in vivo LQ model, and clinical outcomes in the future. Although the qLQB model overcomes limitations of V x and has some advancements than LKB model, there are several problems requiring more attention and further study regarding the use of qLQB model in the clinic setting: 1) The qLQB model is based on the LQ model, but the LQ model is not absolutely consistent with the clinical results at all dose ranges. For example, "hypersensitivity phenomenon" at the low dose range (19) ; when the cell survival fraction is less than 10 27 , there is an "exponential inactivation phenomenon"; (20) only the improved LQ model can be used for SBRT, etc.
2) The portion (which kind of cells) in lung damaged for the chief reason of radioactive pneumonia was not realized. The survival curve of the kind of cells in vivo was not obtained, and the kind of cells distribution in lung was not realized. 3) Radiation injury should include both lethal and nonlethal injury, but the qLQB model only includes lethal injury. 4) When establishing the qLQB model, we assume very part of lung has the same radiation sensitivities, but studies showing that the radiation sensitivities of upper lobe lung and lower lobe lung are different. We also have not introduced time, cell proliferation and apoptosis parameters in our work, with further research needed, while introducing biological factors into evaluation of a plan will be an important research direction.
In the clinical setting, the occurrences of radiation induced complications are affected by many factors such as radioactive pneumonia, advanced age, chemotherapy and surgeries, etc. Moreover, many cytokines such as TGF-β, IL-6, IL-10 play a complex function in radiation pneumonia (21, 22) .
The effectiveness of using the qLQB model in evaluating RIPI was confirmed.
Appendix I: The Establishment of qLQB Model and LKB Model

The Establishment of qLQB Model
For radiobiology and radiotherapy, the function which can be described as a connection between exposed dose and cell survival fraction is very significant (23, 24) . In 1956, Puck established the first cell survival experimental curves of mammal cells when he studied the quantitative relation of irradiation dose and cell survival fraction. The curve shape could be described by the presence of an initial slope at low doses, followed by a shoulder and a final slope at the high dose end of the survival curve (25). Subsequent experiments display the shape of cell survival curves is varied because of cell lines, dose rate, etc (26, 27) .
Studies of the shape of cell survival curves and general mathematical models have important objectives. Radiation oncology investigators have established some mathematical models to fit experimental data including the index deactivation mathematical model, SF 5 e 2αD ; single-hit multi-target model, SF 5 1 2 (1 -e 2kD ) N ; and LQ model, SF 5 e 2αD2βD 2 . However, universal theory on cell deactivation after irradiation in vivo has been not realized up to now.
The LQ model is one of general applied representative mathematical models for cell survival analysis (28, 29) . It is hypothesized that deactivated cells consist of two parts, one part is proportional to irradiation dose -αD, and the other is proportional to the square of irradiation dose -βD 2 .
SF 5 e 2αD2βD 2 [A1]
Here, SF is cell survival fraction of cells which are exposed with dose D, and α and β are constants related with ray character and cell kind. Based on the model, we can obtain a continuous curved cell survival curve, and the relationship between D and SF is degressive and one-to-one.
Aiming at utilization conveniences, in this paper we define the LQ model into unit volume (cm 3 ), given by
Here, sf is the cell survival fraction of cells in a unit volume (cm 3 ) exposed with dose d. Then cell survival fraction of cells in a unit volume, sf(n), after n fractions with a dose of d per fraction, is given by
When evaluating plan or selecting the best plan, radiotherapists usually evaluate and compare the dose-volume-histogram (DVH), while ignoring the dose-volume-differentialhistogram (dDVH), which results in us losing some information that may be important.
With dDVH in a designed plan, we can acknowledge exactly the percentage volume f 1 (D) of lung which is exposed at dose D. Assuming the integral volume of lung is V s , the volume which is exposed at dose D is V D If we substitute d into [A3], we can acquire sf(n) in a unit volume (cm 3 ) after n fractions with a dose of d Gy per fraction. Assuming the number of cells in a unit volume (cm 3 ) is A, and the number of survival cell in a unit volume (cm 3 ) is a, then the a is given by
In the volume of lung which is exposed at dose D, the total number of survival cell b is:
Joining [A3-A7], the available formula is given by:
Then, by summing all the b values, we will obtain the sum of the number of survival cells in lung (except the part in lung which is not exposed to ray) after irradiation. Here, D max is the maximum dose which is exposed on lung per fraction in the plan.
By formula [A9], radiotherapists can acquire b sum for selecting the best plan, in terms of lung, among several plans for the same patient, which is adequately demonstrated in our other paper (30) .
Assuming the integral exposed volume of lung is V, we can acquire a formula, through which we can easily acquire the ratio/percent (R/P) between damaged cell and entire cell of lung. The formula is given by:
LKB Model with EUD
To evaluate the effectiveness of the LQ-based clinical model, we randomly evaluated 45 lung cancer patients who were treated with radiation therapy in our institution. We designed plans on ELEKTA precise 2.12 system for every patient, ELEKTA precise 2.12 system select pencil-beam model for calculating absorb dose in vivo.
We have calculated RP value of lungs in 45 plans for 45 patents. Then the results were contrasted with the results from Lyman-Kutcher-Burman (LKB) model by SPSS17.0 software. We chose two terms of parameters for the LKB model: n 5 0.65, m 5 0.1, TD 50 5 22 Gy (30) and n 5 0.87, m 5 0.18, TD 50 5 24.5 Gy (8) respectively. EUD: Equivalent uniform dose (EUD) is raised by Niemierko for calculating biological effect of organ at risk (OAR). When some nonuniform dose is exposed on the OAR, a biological effect is generated. A uniform dose which can generate the equal effect is called EUD. The EUD's value is given by (8):
Where N is the number of OAR voxel, d i is the dose exposed on the ith voxel, and a is a parameter which is used to describe OAR's biological character. α ∈ [2, 20]; when a  1, the format [A11] is used to calculate tumor EUD; when a  1, the format [A11] is used to calculate "serial organ" EUD; when a 5 1, the format [A11] is used to calculate "parallel organ" EUD (1, 31) . m is a dimensionless parameter and TD 50 is the whole organ dose for which NTCP is 50%.
For the case of uniform irradiation of a fractional volume v to dose D, Lyman gives the NTCP by the same formula with TD 50 replaced by a partial-volumedependent parameter TD 50 (v), given by TD 50 (v) 5 TD 50 (1) 3 v 2n [A14]
The exponent with n  0, is the parameter that determines volume dependence and TD 50 (1) 5 TD 50 , the value for uniform organ irradiation. For the sake of brevity in the following, when the meaning is clear from the context, we shall simple abbreviate TD 50 (1) as TD 50 . The fractional volume v is written as v 5 V/V ref where V ref is a referenced volume for the OAR, usually taken to refer to the entire volume of the OAR.
Then LKB model based on EUD is given by u 5 (EUD 2 TD 50 )/(mTD 50 ) [A15]
